908 Devices to Participate in Upcoming November 2022 Investor Conferences

02 Nov 2022
www.biospace.com
BOSTON--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in the following investor conferences in New York, NY. Stifel 2022 Healthcare Conference Fireside Chat on Wednesday, November 16th at 1:15 p.m. Eastern Time / 10:15 a.m. Pacific Time Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum Fireside Chat on Thursday, November 17th at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time Interested parties may access a live and archived webcast of the virtual sessions on the “Investors” section of the company website at: . About 908 Devices 908 Devices Inc. (Nasdaq: MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation and machine learning. View source version on businesswire.com: Contacts Media Barbara Russo brusso@908devices.com Investor Carrie Mendivil IR@908devices.com Source: 908 Devices Inc View this news release online at:
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.